<DOC>
	<DOCNO>NCT01860196</DOCNO>
	<brief_summary>This study aim compare efficacy safety Meditoxin® injection cervical dystonia adult cerebral palsy . It placebo control , Cross-over , Double blind , Randomized , Clinical trial .</brief_summary>
	<brief_title>Efficacy Safety Meditoxin® Injection Cervical Dystonia Adults With Cerebral Palsy</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<criteria>Adult cerebral palsy patient 20 year old Clinically diagnosed cervical dystonia year ago No improvement antispasmodic last month Actively participate give inform consent Allergic botulinum toxin Limited range motion cervical spine Patients fever , infection , cancer , uncontrollable seizure Generalized neuromuscular junction disease patient Pregnant breast feed woman , anticipate pregnancy 12 week study stop Patients enrolled study History dose change 4 week : antispasmodic , benzodiazepine , anticholinergic Botulinum toxin injection history 6 month Previous history intrathecal baclofen , selective peripheral denervation , deep brain stimulation Otherwise clinically noneligible patient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>